SAN FRANCISCO — Over the past three years that Meena Seshamani has led the Middle for Medicare, the service has seen sweeping change — a lot of it pushed by the passage of the Inflation Discount Act of 2022, she mentioned. This week, Seshamani highlighted just some of those modifications, together with caps on sure drug costs, as a few of her proudest accomplishments — and gave some parting recommendation on how she did it for the following leaders of Medicare.
“I believe what we now have carried out has very a lot been partaking everybody within the ecosystem. Using knowledge, getting feedback from individuals — one of many favourite components of my job was touring the nation and speaking to individuals who depend on Medicare,” Seshamani mentioned at a STAT occasion alongside the J.P. Morgan Healthcare Convention right here in San Francisco. “I believe that’s the basis of not solely good policymaking, but in addition good operations.”
Medicare is the biggest well being care payer within the nation, paying greater than a trillion {dollars} in claims a 12 months. “It’s essential for anybody in that position and anybody main a staff of over 1,000 individuals, over 10,000 contractors, to method that in a considerate method,” Seshamani continued.
This text is unique to STAT+ subscribers
Unlock this text — plus each day intelligence on Capitol Hill and the life sciences business — by subscribing to STAT+.
Have already got an account? Log in
View All Plans
